Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Dipeptidyl peptidase-IV and related molecules: markers of malignancy?

1 Jun 2008

Abstract excerpt

BACKGROUND: The dipeptidyl peptidase-IV (DPP-IV) family has outgrown its humble origins as a simple enzymatic activity cleaving dipeptides from peptides with an accessible N-terminal penultimate proline with no clear role in metabolism. It is now understood to play a critical role in regulating signaling capacity of chemokines, neuropeptides and other extracellular messengers in addition to playing direct roles...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Diabetes Treatment and Management
Share to Neuropeptides and Animal Physiology
Share to Peptidase Inhibition and Analysis

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 23495778
DOI: 10.1517/17530059.2.6.677

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Dipeptidyl peptidase-IV and related molecules: markers of malignancy?PMID 23495778Read ↗

The dipeptidyl peptidase IV family in cancer and cell biologySemantic proximity Read ↗

Identification of Dipeptidyl Peptidase (DPP) Family Genes in Clinical Breast Cancer Patients via an Integrated Bioinformatics ApproachSemantic proximity Read ↗

Integrated Analysis Identifies DPP7 as a Prognostic Biomarker in Colorectal CancerSemantic proximity Read ↗

Genetic variants of dipeptidyl peptidase IV are linked to the clinicopathologic development of prostate cancer.Semantic proximity Read ↗

Involvement of Kallikrein-Related Peptidases in Normal and Pathologic ProcessesSemantic proximity Read ↗

Dipeptidyl Peptidase IV as a Novel Prognostic Marker and Important Therapeutic Target in MelanomaSemantic proximity Read ↗

CD26/Dipeptidyl Peptidase IV as a Novel Therapeutic Target for Cancer and Immune DisordersSemantic proximity Read ↗

TMPRSS4, a type II transmembrane serine protease, as a potential therapeutic target in cancerSemantic proximity Read ↗

Clinical utility of kallikrein-related peptidases (KLK) in urogenital malignancies.Semantic proximity Read ↗

Kallikrein-related peptidases: mechanistic understanding for potential therapeutic targeting in cancerSemantic proximity Read ↗

Kallikrein-related peptidases (KLKs) and the hallmarks of cancerSemantic proximity Read ↗

Kallikrein-related peptidases (KLKs): a gene family of novel cancer biomarkersSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.